The trademark application NXIVRYS was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 24, 2021, and it was registered by office on August 30, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).